Skip to the content
Search
Beyond Type 2
Menu
BEYOND TYPE 2
Show sub menu
About
Our Story
Founding Partners
Board of Directors
Leadership Council
The Team
Join Us
Contact
Diabetes
Type 1 Info
Type 2 Info
Prediabetes Info
Forms of Diabetes
Newly Diagnosed
Diabetes Management
Pregnancy and Diabetes
Resources
GetInsulin.org
Insulin for T2D
Diabetes Management
Understanding T2D
Exercise
Food
Heart Health
Mental Health
Continuous Glucose Monitoring (CGM)
Veterans with Diabetes
Beyond Type 2 Advocacy
Stories
Diabetes News
Type 2 Stories
Community
Beyond Type 2 App
Marathon Team
En Español
Search
Author:
Kayla Hui
The Latinx Diabetes Initiative Provides Culturally Tailored Care To Latinx Patients With Diabetes
Andreina Millan Ferro is centering culturally sensitive diabetes care for Latinx patients with diabetes at the Latinx Diabetes Initiative.
Empowering Youth Through Diabetes Education In Mexico
Yarishdy Mora is the director of the Youth Health Program for Project HOPE in Mexico. She creates platforms that help youth learn about diabetes.
Overweight Adults to Now Be Screened for Type 2 Diabetes At 35
The U.S. Preventive Services Task Force now recommends overweight and obese adults to get screened for Type 2 diabetes at the age of 35.
Pandemic Homelessness Disproportionately Impacts People With Diabetes
An American Diabetes Association report found that pandemic homelessness hit people with diabetes 48 times harder.
Abbott’s FreeStyle Libre 2 App Receives FDA Clearance
On August 2, 2021, the FDA approved the FreeStyle Libre 2 app for adults and children with diabetes, allowing user to access glucose readings directly from their iPhone.
FDA Approves Senza®, Nevro’s High Frequency Spinal Cord Stimulation Therapy For PDN
The Senza System has been approved by the FDA for the treatment of chronic pain associated with painful diabetic neuropathy.
Semglee Receives FDA Approval as First Interchangeable Biosimilar Insulin
Semglee becomes the first interchangeable biosimilar product for the treatment of Type 1 and Type 2 diabetes.
Providing Culturally Sensitive LGBTQ+ Diabetes Health Care
Culturally sensitive LGBTQ+ diabetes health care can decrease stigma and advance diabetes care access for the LGBTQ community.
FDA Approves Kerendia For The Treatment Of Type 2 Diabetes
Kerendia will be available in the U.S. immediately for the treatment of chronic kidney disease associated with Type 2 diabetes.
Using Social Media to Improve Diabetes Care Among Low-Income Chinese Immigrants
Lu Hu discusses how WeChat was used to deliver culturally and linguistically tailored intervention for Chinese immigrants.
Posts navigation
←
Newer
Posts
1
2
3
Older
Posts
→